Skip to main content

Advertisement

SpringerLink
Log in

Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

To understand the influence of the systemic lupus erythematosus (SLE)-related flares on patient’s health-related quality of life (HRQoL).

Methods

An online survey included individuals with self-reported physician’s diagnosis of SLE or lupus nephritis (LN). Lupus impact tracker (LIT) assessed lupus symptoms and HRQoL, SLE-Family questionnaire measured family role functioning, and Healthy Days Core Module (HDCM) measured overall mental and physical health. Chi-square and analysis of variance evaluated differences by flare frequency. Multivariable linear regression and generalized linear models evaluated the independent relationships of flare frequency to HRQoL.

Results

1066 respondents with SLE or LN completed the survey. Mean (SD) duration of illness was 12.4 (10.1) years. 93.4% (n = 996) were women, 82.3% (n = 830) were White, and 49.7% (n = 530) were employed or students. More frequent flares were associated with significantly worse scores on all HRQoL measures: LIT (adjusted means: 0 flares, 31.8; 1–3 flares, 47.0; 4–6 flares, 56.1; ≥ 7 flares, 63.6; P < 0.001); SLE-Family (adjusted means: 0 flares, 3.1; 1–3 flares 3.8; 4–6 flares, 4.3; ≥ 7 flares, 4.6, P < 0.001); HDCM unhealthy days (0 flares, 8.7; 1–3 flares, 17.4; 4–6 flares, 21.5; ≥ 7 flares, 26.2 days, P < 0.001).

Conclusion

Lupus flares contributed to impaired functional and psychological well-being, family functioning, and number of monthly healthy days. Better understanding of the burden of flare activity from the patient’s perspective will support a holistic approach to lupus management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and material

All authors have access to the data. The data can be made available upon written request from the corresponding author.

References

  1. Furst, D. E., Clarke, A. E., Fernandes, A. W., Bancroft, T., Greth, W., & Iorga, S. R. (2013). Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population. Lupus, 22(1), 99–105.

    Article  CAS  Google Scholar 

  2. Garris, C., Shah, M., & Farrelly, E. (2015). The prevalence and burden of systemic lupus erythematosus in a medicare population: Retrospective analysis of medicare claims. Cost Effectiveness and Resource Allocation, 13, 9.

    Article  Google Scholar 

  3. Yazdany, J., & Yelin, E. (2010). Health-related quality of life and employment among persons with systemic lupus erythematosus. Rheumatic Disease Clinics of North America, 36(1), 15–32, vii.

  4. Gordon, C., Isenberg, D., Lerstrom, K., Norton, Y., Nikai, E., Pushparajah, D. S., et al. (2013). The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: A European patient-driven online survey. Rheumatology (Oxford), 52(12), 2292–2301.

    Article  Google Scholar 

  5. Garris, C., Oglesby, A., Sulcs, E., & Lee, M. (2013). Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States. Lupus, 22(10), 1077–1086.

    Article  CAS  Google Scholar 

  6. Elera-Fitzcarrald, C., Fuentes, A., Gonzalez, L. A., Burgos, P. I., Alarcon, G. S., & Ugarte-Gil, M. F. (2018). Factors affecting quality of life in patients with systemic lupus erythematosus: Important considerations and potential interventions. Expert Review of Clinical Immunology, 14(11), 915–931.

    Article  CAS  Google Scholar 

  7. Yelin, E., Trupin, L., & Yazdany, J. (2017). A prospective study of the impact of current poverty, history of poverty, and exiting poverty on accumulation of disease damage in systemic lupus erythematosus. Arthritis Rheumatol, 69(8), 1612–1622.

    Article  Google Scholar 

  8. Monahan, R. C., Beaart-van de Voorde, L. J. J., Steup-Beekman, G. M., Magro-Checa, C., Huizinga, T. W. J., Hoekman, J., et al. (2017). Neuropsychiatric symptoms in systemic lupus erythematosus: Impact on quality of life. Lupus, 26(12), 1252–1259.

    Article  CAS  Google Scholar 

  9. Golder, V., Kandane-Rathnayake, R., Hoi, A. Y., Huq, M., Louthrenoo, W., An, Y., et al. (2017). Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. Arthritis Research and Therapy, 19(1), 62.

    Article  Google Scholar 

  10. Legge, A., Doucette, S., & Hanly, J. G. (2016). Predictors of organ damage progression and effect on health-related quality of life in systemic lupus erythematosus. Journal of Rheumatology, 43(6), 1050–1056.

    Article  Google Scholar 

  11. Moldovan, I., Katsaros, E., Carr, F. N., Cooray, D., Torralba, K., Shinada, S., et al. (2011). The patient reported outcomes in lupus (PATROL) study: Role of depression in health-related quality of life in a Southern California lupus cohort. Lupus, 20(12), 1285–1292.

    Article  CAS  Google Scholar 

  12. Alarcon, G. S., McGwin, G., Jr., Uribe, A., Friedman, A. W., Roseman, J. M., Fessler, B. J., et al. (2004). Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis and Rheumatism, 51(3), 465–474.

    Article  Google Scholar 

  13. Thumboo, J., Fong, K. Y., Chan, S. P., Leong, K. H., Feng, P. H., Thio, S. T., et al. (2000). A prospective study of factors affecting quality of life in systemic lupus erythematosus. Journal of Rheumatology, 27(6), 1414–1420.

    CAS  PubMed  Google Scholar 

  14. Ruperto, N., Hanrahan, L. M., Alarcon, G. S., Belmont, H. M., Brey, R. L., Brunetta, P., et al. (2011). International consensus for a definition of disease flare in lupus. Lupus, 20(5), 453–462.

    Article  CAS  Google Scholar 

  15. Meacock, R., Dale, N., & Harrison, M. J. (2013). The humanistic and economic burden of systemic lupus erythematosus: A systematic review. Pharmacoeconomics, 31(1), 49–61.

    Article  Google Scholar 

  16. Olesinska, M., & Saletra, A. (2018). Quality of life in systemic lupus erythematosus and its measurement. Reumatologia, 56(1), 45–54.

    Article  Google Scholar 

  17. Kulczycka, L., Sysa-Jedrzejowska, A., & Robak, E. (2010). Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations. Clinical Rheumatology, 29(9), 991–997.

    Article  Google Scholar 

  18. Golder, V., Ooi, J. J. Y., Antony, A. S., Ko, T., Morton, S., Kandane-Rathnayake, R., et al. (2018). Discordance of patient and physician health status concerns in systemic lupus erythematosus. Lupus, 27(3), 501–506.

    Article  CAS  Google Scholar 

  19. Mok, C. C., Ho, L. Y., Cheung, M. Y., Yu, K. L., & To, C. H. (2009). Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: A 2-year prospective study. Scandinavian Journal of Rheumatology, 38(2), 121–127.

    Article  CAS  Google Scholar 

  20. Khanna, S., Pal, H., Pandey, R. M., & Handa, R. (2004). The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford), 43(12), 1536–1540.

    Article  CAS  Google Scholar 

  21. Mozaffarian, N., Lobosco, S., Lu, P., Roughley, A., & Alperovich, G. (2016). Satisfaction with control of systemic lupus erythematosus and lupus nephritis: Physician and patient perspectives. Patient Prefer Adherence, 10, 2051–2061.

    Article  Google Scholar 

  22. Leong, K. P., Chong, E. Y., Kong, K. O., Chan, S. P., Thong, B. Y., Lian, T. Y., et al. (2010). Discordant assessment of lupus activity between patients and their physicians: The Singapore experience. Lupus, 19(1), 100–106.

    Article  CAS  Google Scholar 

  23. Yen, J. C., Neville, C., & Fortin, P. R. (1999). Discordance between patients and their physicians in the assessment of lupus disease activity: Relevance for clinical trials. Lupus, 8(8), 660–670.

    Article  CAS  Google Scholar 

  24. Katz, P., Nelson, W. W., Daly, R. P., Topf, L., Connolly-Strong, E., & Reed, M. L. (2020). Patient-reported lupus flare symptoms are associated with worsened patient outcomes and increased economic burden. Journal of Managed Care & Specialty Pharmacy, 26(3), 275–283.

    Article  Google Scholar 

  25. Centers for Disease Control and Prevention. (2018). Lupus Research Studies. Retrieved December 23, 2019, from https://www.cdc.gov/lupus/funded/lupus-studies.htm

  26. Jolly, M., Garris, C. P., Mikolaitis, R. A., Jhingran, P. M., Dennis, G., Wallace, D. J., et al. (2014). Development and validation of the Lupus Impact Tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Research (Hoboken), 66(10), 1542–1550.

    Article  Google Scholar 

  27. Hassett, A. L., Li, T., Radvanski, D. C., Savage, S. V., Buyske, S., Schiff, S. A., et al. (2012). Assessment of health-related family role functioning in systemic lupus erythematosus: preliminary validation of a new measure. Arthritis Care Research (Hoboken), 64(9), 1341–1348.

    Article  Google Scholar 

  28. Hennessy, C. H., Moriarty, D. G., Zack, M. M., Scherr, P. A., & Brackbill, R. (1994). Measuring health-related quality of life for public health surveillance. Public Health Reports, 109(5), 665–672.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Graham, J., & Hofer, S. (2000). Modeling longitudinal and multiple group data: Practical issues, applied approaches, and specific examples. Mahwah, NJ: Lawrence Erlbaum Associates.

    Google Scholar 

  30. Yacoub Wasef, S. Z. (2004). Gender differences in systemic lupus erythematosus. Gender Medicine, 1(1), 12–17.

    Article  Google Scholar 

  31. Katz, P., Yazdany, J., Julian, L., Trupin, L., Margaretten, M., Yelin, E., et al. (2011). Impact of obesity on functioning among women with systemic lupus erythematosus. Arthritis Care Research (Hoboken), 63(10), 1357–1364.

    Article  Google Scholar 

  32. Majka, D. S., & Holers, V. M. (2006). Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis. Annals of the Rheumatic Diseases, 65(5), 561–563.

    Article  CAS  Google Scholar 

  33. Lateef, A., & Petri, M. (2012). Unmet medical needs in systemic lupus erythematosus. Arthritis Research and Therapy, 14(Suppl 4), S4.

    Article  Google Scholar 

  34. Squance, M. L., Reeves, G. E., & Bridgman, H. (2014). The lived experience of lupus flares: Features, triggers, and management in an Australian Female Cohort. International Journal of Chronic Diseases, 2014, 816729.

    Article  Google Scholar 

  35. Kan, H. J., Song, X., Johnson, B. H., Bechtel, B., O'Sullivan, D., & Molta, C. T. (2013). Healthcare utilization and costs of systemic lupus erythematosus in Medicaid. BioMed Research International, 2013, 808391.

    PubMed  Google Scholar 

Download references

Acknowledgements

Valerie Marske of Vedanta Research supported survey instrument development as well and data collection, Kristina Fanning, PhD provided analytical support, and Dana Franznick, PharmD and Ishveen Chopra, PhD provided medical writing support. This study was funded by Mallinckrodt Pharmaceuticals.

Funding

This study was funded by Mallinckrodt Pharmaceuticals, Bedminster, New Jersey via grants to Vedanta Research and the Lupus Foundation of America.

Author information

Authors and Affiliations

  1. School of Medicine, University of California San Francisco, San Francisco, CA, USA

    Patricia Katz

  2. Global Head of Health Economics and Outcomes Research, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA

    George J. Wan & Erin Connolly-Strong

  3. The Lupus Foundation of America, Washington, DC, USA

    Paola Daly & Lauren Topf

  4. Vedanta Research, Chapel Hill, NC, USA

    Ryan Bostic & Michael L. Reed

  5. Field Medical Affairs, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA

    Erin Connolly-Strong

  6. Arthritis Research Group, University of California San Francisco, 3333 California Street, San Francisco, CA, 94143-0936, USA

    Patricia Katz

Authors
  1. Patricia Katz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George J. Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paola Daly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lauren Topf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erin Connolly-Strong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ryan Bostic
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael L. Reed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patricia Katz.

Ethics declarations

Conflict of interest

GJW and EC-S are employees of Mallinckrodt Pharmaceuticals, and are stockholders of the company. PK is a paid consultant of Vedanta Research. MLR and RB are paid consultants of Mallinckrodt Pharmaceuticals. PD was previously an employee of Lupus Foundation of America and LT is a current employee of Lupus Foundation of America, which received grant funding to support study data collection.

Ethics approval

Ethical and Independent Review Services (Independence, MO) reviewed the study methods, consent form, and survey tools and certified that the study (#16149–01) was exempt from the Code of Federal Regulation 45 CFR 46.101(b) on 20 December 2016.

Informed consent

Study respondents provided electronic informed consent before beginning the survey.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katz, P., Wan, G.J., Daly, P. et al. Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus. Qual Life Res 29, 3251–3261 (2020). https://doi.org/10.1007/s11136-020-02572-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-020-02572-9

Keywords

Search

Navigation